Ledger.Open graph →
SEC Form D · filed May 2, 2014

Kite Pharma, Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SANTA MONICA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Roy B. Doumani · Santa Monica, CADirectorJoshua A. Kazam · San Francisco, CADirectorMargo R. Roberts · Santa Monica, CAExecCynthia M. Butitta · Santa Monica, CAExecDavid A. Bonderman · Santa Monica, CADirectorJonathan M. Peacock · Santa Monica, CADirectorArie S. Belldegrun · Parsippany, NJExec · DirectorMarc R. Better · Santa Monica, CAExecFarah B. Champsi · Santa Monica, CADirectorRan B. Nussbaum · Santa Monica, CADirectorSteven B. Ruchefsky · Santa Monica, CADirectorRizwana R. Sproule · Santa Monica, CAExecKeith M. Nolop · Santa Monica, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗